CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-11-22 | Aryeh Jason Director | Sale | −15,001 | $107.40 | $1.6M | 189,376 |
| 2016-11-18 | Aryeh Jason Director | Sale | −5,000 | $105.00 | $525K | 204,377 |
| 2016-11-16 | Aryeh Jason Director | Sale | −1,330 | $106.33 | $141K | 209,377 |
| 2016-10-31 | Davis Todd C Director | Exercise or conversion | +3,333 | $53.34 | $178K | 59,542 |
| 2016-10-31 | Davis Todd C Director | Exercise or conversion | +7,335 | $32.30 | $237K | 66,877 |
| 2016-10-31 | Davis Todd C Director | Exercise or conversion | +3,312 | $67.53 | $224K | 70,189 |
| 2016-10-31 | Davis Todd C Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,335 | 0 | ||
| 2016-10-31 | Davis Todd C Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −3,333 | 0 | ||
| 2016-10-31 | Davis Todd C Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −3,312 | 0 | ||
| 2016-09-22 | HIGGINS JOHN L Chief Executive Officer | Sale | −3,000 | $117.34 | $352K | 122,664 |
| 2016-09-07 | KOZARICH JOHN W Director | Sale | −1,000 | $115.00 | $115K | 39,983 |
| 2016-09-01 | KOZARICH JOHN W Director | Exercise or conversion | +1,666 | $45.60 | $76K | 40,983 |
| 2016-09-01 | KOZARICH JOHN W Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −1,666 | 0 | ||
| 2016-09-01 | KOZARICH JOHN W Director | Sale | −200 | $103.59 | $21K | 40,783 |
| 2016-09-01 | KOZARICH JOHN W Director | Sale | −400 | $104.66 | $42K | 40,383 |
| 2016-09-01 | KOZARICH JOHN W Director | Sale | −866 | $105.82 | $92K | 39,517 |
| 2016-09-01 | KOZARICH JOHN W Director | Sale | −200 | $106.87 | $21K | 39,317 |
| 2016-08-08 | FOEHR MATTHEW W President and COO | Exercise or conversion | +4,125 | $9.97 | $41K | 83,037 |
| 2016-08-08 | FOEHR MATTHEW W President and COO | Exercise or conversion · Employee Stock Option (right to buy) | −4,125 | 66,735 | ||
| 2016-08-06 | Korenberg Matthew E VP, Finance and CFO | Shares withheld for taxes | −609 | $123.30 | $75K | 9,457 |
Page 60 of 86 · 1,712 trades